Should Physician Plead Guilty in All Practice Leading to Patient Mortality
Article Sidebar
Published:
Dec 1, 2017
Keywords:
amniotic fluid embolism suilty violation mortolity
Main Article Content
Abstract
The process of Physician health care could lead to adverse patient outcomes, intentionally or otherwise. In the events that harms occurred, physicians had plead guilty for violation of law despite the fact that informed consent had already been obtained. According to the verdict of the Supreme Court of Thailand in the past, cases of amniotic fluid embolism or Steven-Johnson syndrome have been considered “force majeure” legally. Accordingly, physicians involved has usually been acquitted in these cases in the past.
Article Details
How to Cite
Nualchaem, C. (2017). Should Physician Plead Guilty in All Practice Leading to Patient Mortality. Vajira Medical Journal : Journal of Urban Medicine, 61(4), 319–326. Retrieved from https://he02.tci-thaijo.org/index.php/VMED/article/view/196122
Section
Case Report
References
1. Dildy GA, Clark Sl. Amniotic fluid embolism In: Foley MR, Strong TH Jr, editors. Obstetrics intensive care:a practical manual. Philadelphia: W.B Sanders; 1997. p.197–206.
2. Clark Sl, Hankins GCV, Dudley DA, Dildy GA, porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995;72: 1158-69.
3. Spiliopoulos M, Puri I, Jain NJ, Kruse L, Mastrogiannis D, Dandolu V. Amniotic fluid embolism – risk factor, maternal and neonatal outcomes. J Matern Fetal Neonatal Med. 2009;22: 439–44.
4. Clark SL, Pavlava Z, Greenspoon J, Horenstein J,Phelan JP, Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol. 1986;154: 104–6.
5. Lee KR, Catalano PM, Ortiz-Giroux S. Cytology diagnosis of amniotic fluid embolism. Report of a case with a unique cytologic feature and emphasis on the difficulty of eliminating squamous contamination. Acta Cytol. 1986;30:177–82.
6. Fineschi V, Gambassi R, Gherardi M, Turillazzi E. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase. Int J Legal Med. 1998;111: 238–43.
7. Khong TY. Expression of endothelin – 1 in amniotic fluid embolism and possible pathophysiological mechanism. Br J Obstset Gynecol. 1998;105: 802–4.
8. Benson MD, Kobayasshi H, Silver RK, Oi H, Greenberger PA, Terao T. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol. 2001;97: 510–4.
9. Mason RG. Amniotic fluid embolism. Clin Chest Med. 1992;13: 657–65.
10. Kobayashi H, Ohi H, Terao T. A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH – 2 that recognized NeuAc alpha 2 – 6 GalNAc. Am J Obstet Gynecol. 1993;168; 848–53.
11. Kanayama N, Yamazaki T, Naruse H, Sumimoto K, Horiuchi K, Terao T. Determining zinc coproporphyrin in maternal plasma – a new method for diagnosing amniotic fluid embolism. Clin Chem. 1992;38: 526-9.
12. Cheung ANY, Luk SC. The importance of expensive sampling and examination of cervix in suspected cases of amniotic fluid embolism. Arch Gynecol Obstet. 1994;255: 101-5.
13. Hsieh YY, Chang CC, Li PC, Tsai HD, Tsai CH. Successful application of extracorporeal membrane oxygenation and intra – aortic balloon counter-pulsation as life-saving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol. 2000;183:(2):496-7.
14. Stafford I, Sheffield J. Amniotic fluid ambolism. Obstet Gynecol Clin North Am. 2007;34: 545-53.
15. Ho CH, Chen KB, Lin SK, Cheng HC, Wu RS. Early application of extracorporeal membrane oxygenation in a patient with amniotic fluid embolism. Acta Anaesthesiol Taiwan. 2009;47(2):99-102.
16. Rodgers GP, Heymach GJ III. Cryoprecipitate therapy in amniotic fluid embolization. Am J Med. 1984;76: 916-20.
17. Capellier G, Jacques T, Balvay P, Blasco G, Belle E, Barale F. Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med. 1997;23: 1098-92.
18. Van Heerden PV. Webb SAR, Hee G, Corkeron M, Thompson WR. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxemia. Anaesth Intensive Care. 1996;24: 87-90.
2. Clark Sl, Hankins GCV, Dudley DA, Dildy GA, porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995;72: 1158-69.
3. Spiliopoulos M, Puri I, Jain NJ, Kruse L, Mastrogiannis D, Dandolu V. Amniotic fluid embolism – risk factor, maternal and neonatal outcomes. J Matern Fetal Neonatal Med. 2009;22: 439–44.
4. Clark SL, Pavlava Z, Greenspoon J, Horenstein J,Phelan JP, Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol. 1986;154: 104–6.
5. Lee KR, Catalano PM, Ortiz-Giroux S. Cytology diagnosis of amniotic fluid embolism. Report of a case with a unique cytologic feature and emphasis on the difficulty of eliminating squamous contamination. Acta Cytol. 1986;30:177–82.
6. Fineschi V, Gambassi R, Gherardi M, Turillazzi E. The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase. Int J Legal Med. 1998;111: 238–43.
7. Khong TY. Expression of endothelin – 1 in amniotic fluid embolism and possible pathophysiological mechanism. Br J Obstset Gynecol. 1998;105: 802–4.
8. Benson MD, Kobayasshi H, Silver RK, Oi H, Greenberger PA, Terao T. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol. 2001;97: 510–4.
9. Mason RG. Amniotic fluid embolism. Clin Chest Med. 1992;13: 657–65.
10. Kobayashi H, Ohi H, Terao T. A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH – 2 that recognized NeuAc alpha 2 – 6 GalNAc. Am J Obstet Gynecol. 1993;168; 848–53.
11. Kanayama N, Yamazaki T, Naruse H, Sumimoto K, Horiuchi K, Terao T. Determining zinc coproporphyrin in maternal plasma – a new method for diagnosing amniotic fluid embolism. Clin Chem. 1992;38: 526-9.
12. Cheung ANY, Luk SC. The importance of expensive sampling and examination of cervix in suspected cases of amniotic fluid embolism. Arch Gynecol Obstet. 1994;255: 101-5.
13. Hsieh YY, Chang CC, Li PC, Tsai HD, Tsai CH. Successful application of extracorporeal membrane oxygenation and intra – aortic balloon counter-pulsation as life-saving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol. 2000;183:(2):496-7.
14. Stafford I, Sheffield J. Amniotic fluid ambolism. Obstet Gynecol Clin North Am. 2007;34: 545-53.
15. Ho CH, Chen KB, Lin SK, Cheng HC, Wu RS. Early application of extracorporeal membrane oxygenation in a patient with amniotic fluid embolism. Acta Anaesthesiol Taiwan. 2009;47(2):99-102.
16. Rodgers GP, Heymach GJ III. Cryoprecipitate therapy in amniotic fluid embolization. Am J Med. 1984;76: 916-20.
17. Capellier G, Jacques T, Balvay P, Blasco G, Belle E, Barale F. Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med. 1997;23: 1098-92.
18. Van Heerden PV. Webb SAR, Hee G, Corkeron M, Thompson WR. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxemia. Anaesth Intensive Care. 1996;24: 87-90.